Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

 SummaryQuotesNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
More Financials
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on... 
More about the company
Latest news on OSIRIS THERAPEUTICS, INC.
05:32a OSIRIS THERAPEUTICS : restates financial reports to show $10 million loss in 201..
03/27 OSIRIS THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regul..
03/27 Osiris Therapeutics, Inc. Completes Restatement of 2014 Financial Statements
03/27 OSIRIS THERAPEUTICS : 10-K/A - Management's Discussion and Analysis of Financial..
03/14 OSIRIS THERAPEUTICS, INC. : NASDAQ Decides to Delist Osiris Therapeutics, Pulmat..
03/11 OSIRIS THERAPEUTICS : Receives Notice of Delisting from NASDAQ
03/10 OSIRIS THERAPEUTICS,INC. (NASDAQ : OSIR) Files An 8-K Notice of Delisting or Fai..
03/10 Osiris Receives Notice of Delisting from NASDAQ
03/10 OSIRIS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continue..
02/12 OSIRIS THERAPEUTICS,INC. (NASDAQ : OSIR) Files An 8-K Departure of Directors or ..
More news
Sector news : Bio Therapeutic Drugs
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
More sector news : Bio Therapeutic Drugs
Latest Tweets
05:01pHealthcare - Top 5 Gainers / Losers as of 11:00 am  
03/22$ILUS bids building, now that .03 is solid support, we could see an uptrend. .. 
03/21After Hours Gainers / Losers  
03/14Osiris Therapeutics Inc. (OSIR) Tumbled After NASDAQ Moves To Delist: Osiris .. 
03/13Top Losers: $ARLZ -28%. $CERC -21%. $OSIR -19%. $HLTH -19%. $CATB -17%. $CRDS..
8
More tweets
Qtime:12
News from SeekingAlpha
11:01a HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
03/21 After Hours Gainers / Losers
03/13 Midday Gainers / Losers
03/13 Trading in Osiris Therapeutics to be suspended tomorrow, formal delisting to ..
03/13 HEALTHCARE - TOP 5 GAINERS / LOSERS : 10 pm
Advertisement
Technical analysis trends OSIRIS THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David A. Dresner President & Chief Executive Officer
Peter A. Friedli Chairman
Frank D. Czworka Chief Operating Officer
Gregory I. Law Chief Financial Officer, Secretary & Treasurer
Alla Danilkovitch Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
OSIRIS THERAPEUTICS, I..0.00%136
AMGEN, INC.12.79%121 448
CELGENE CORPORATION7.87%97 137
GILEAD SCIENCES, INC.-5.74%88 227
REGENERON PHARMACEUTIC..4.52%40 701
ACTELION LTD24.40%29 848
More Results